30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Nathaniel Gardiner

Track

Insider profile

Currently holds a position at Enanta Pharmaceuticals Inc

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -25% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President, General Counsel Enanta Pharmaceuticals Inc May 1, 2014 -
Nathaniel Gardiner's trades of Enanta Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-06 2023-12-05
S Sale
69,635 +46.2%
379.87
US$1,387,754 		69,635 +46.2% 379.87 US$1,387,754
2019-02-13 2019-02-13
PlS Planned sale
26,066 -21.6%
179.41
US$2,214,765 		26,066 -21.6% 179.41 US$2,214,765